Current research and development
Zymetech is a knowledge based biotechnology company actively involved in research and development
Ongoing research projects.
1. Viral and bacterial infections. The antipathogenic activity of unique formulations containing Penzyme is supported by recent research data. Pathogenic strains tested include avian, swine and human influenza, cold viruses, Herpes, skin and oral bacteria and resistant bacterial strains such as MRSA. Research on the antipathogenic properties of Penzyme against bacteria, viruses and yeast is being actively pursued.
2. Clinical trials on the antipathogenic activity of unique formulations containing Penzyme.
3. Expression of recombinant cod trypsin in microbes.
Development.
1. SaliZyme nasal wash. A special formulation containing Penzyme.
2. BiofilmZyme, a novel formulation containing penzyme to control bacterial and fungal biofilms.
3. New improved and advanced cosmetic Penzyme formulations, HyalZyme, LipHaZyme and Lipha-PENZIM, have recently been developed. These new formulations are highly regarded by our testers and are considered to be the ultimate clean cosmetic formulations of the future. The Zymetech protein formulations are now also being used by other cosmetics companies for their protein products.